Efficacy and Safety Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive Disorder

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

March 31, 2012

Study Completion Date

April 30, 2012

Conditions
Depressive Disorder, Major
Interventions
DRUG

Vortioxetine

Vortioxetine tablets

DRUG

Placebo

Vortioxetine placebo-matching tablets

Trial Locations (70)

Unknown

Split

Zagreb

Helsinki

Kuopio

Oulu

Tampere

Berlin

Bochum

Chemnitz

Hanover

Leipzig

München

Nuremberg

Schwerin

Westerstede

Wiesbaden

Hong Kong

Hyderabad

Ahmedabad

Kanpur

Lucknow

Varanasi

Tokoname-shi

Fukuoka

Kitakyushu-shi

Omuta-shi

Shirakawa-shi

Sapporo

Yokohama

Kumamoto

Tokyo

Liepāja

Riga

Sigulda

Johor Bahru

Kuala Lumpur

Makati City

Mandaluyong

Manila

Quezon City

Bialystok

Gorlice

Leszno

Torun

Żuromin

Iași

Târgu Mureş

Bucharest

Nizhny Novgorod

Rostov-on-Don

Saint Petersburg

Smolensk

Stavropol

Yekaterinburg

Belgrade

Kragujevac

Senta

Sungnam-si

Incheon

Seoul

Yangsan

Changhua

Kaohsiung City

Taipei

Taoyuan Hsien

Chernigiv Region

Dnipropetrovsk

Kharkiv

Kiev

Luhansk

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY